Literature DB >> 22048654

The pattern of lymph node metastasis and the suitability of 7th UICC N stage in predicting prognosis of remnant gastric cancer.

Fangxuan Li1, Rupeng Zhang, Han Liang, Hui Liu, Jichuan Quan, Jingzhu Zhao.   

Abstract

BACKGROUNDS: The original disease and previous operation usually cause abnormal lymphatic drainage of remnant gastric cancer (RGC). We analyzed metastatic lymph nodes (MLNs) of RGCs to explore the pattern of lymphatic metastasis and rational surgical treatment for RGC.
METHODS: Eighty-three RGC patients who underwent radical gastrectomy from July 1991 to July 2008 enrolled in this retrospective analysis.
RESULTS: Original disease, tumor size, Borrmann type, depth of invasion, and histological type were related to an increased risk of lymph node (LN) metastasis (P < 0.05). Multivariate logistic analysis revealed that tumor size and depth of invasion were independent predictive factors of LN metastasis (P < 0.05). In comparison with upper one-third gastric cancer, patients with RGC tended to have a lower incidence of perigastric LN metastasis and higher incidence of metastasis to the mesojejunum and lower mediastinal LNs. A high incidence of MLNs in the No. 14 and mesojejunum was found from the patients who had previously undergone Billroth II reconstruction, while patients after Billroth I reconstruction had higher No. 12 and No. 13 LN metastasis rates. Cut-point survival analysis demonstrated that the most appropriate cutoffs of MLNs were set at 0, 2, 6, and 9. Patients of 0, 1-2, 3-6, 7-9, or ≥10 MLNs presented with median survival time of 37, 35, 24, 13, and 9 month, respectively.
CONCLUSIONS: Preoperative diagnosis of depth of invasion and tumor size can help surgeons to evaluate LN metastasis. The 7th UICC N stage may be unsuitable and should be evaluated and improved in order to help surgeons rationally to estimate N stage of RGC.

Entities:  

Mesh:

Year:  2011        PMID: 22048654     DOI: 10.1007/s00432-011-1034-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Gastric remnant carcinoma: just another proximal gastric cancer or a unique entity?

Authors:  E Newman; M F Brennan; S N Hochwald; L E Harrison; M S Karpeh
Journal:  Am J Surg       Date:  1997-04       Impact factor: 2.565

2.  Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.

Authors:  Erhan Reis; Nuri Aydin Kama; Mutlu Doganay; Mesut Atli; Mete Dolapci
Journal:  Hepatogastroenterology       Date:  2002 Jul-Aug

3.  A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC.

Authors:  Frederick L Greene; Leslie H Sobin
Journal:  J Surg Oncol       Date:  2009-04-01       Impact factor: 3.454

4.  Is extensive lymphadenectomy necessary for surgical treatment of intramucosal carcinoma of the stomach?

Authors:  K Iriyama; T Asakawa; H Koike; H Nishiwaki; H Suzuki
Journal:  Arch Surg       Date:  1989-03

5.  Clinicopathologic differences between gastric remnant cancer and primary cancer in the upper third of the stomach.

Authors:  T Imada; Y Rino; M Takahashi; M Shiozawa; S Hatori; Y Noguchi; T Amano; O Kobayashi; M Sairenji; H Motohashi
Journal:  Anticancer Res       Date:  1998 Jan-Feb       Impact factor: 2.480

6.  Metastatic pattern of lymph node and surgery for gastric stump cancer.

Authors:  Shao-Liang Han; Ya-Wei Hua; Cheng-Hu Wang; She-Qing Ji; Jing Zhuang
Journal:  J Surg Oncol       Date:  2003-04       Impact factor: 3.454

7.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Authors:  Takuji Gotoda; Akio Yanagisawa; Mitsuru Sasako; Hiroyuki Ono; Yukihiro Nakanishi; Tadakazu Shimoda; Yo Kato
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

8.  Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection.

Authors:  Hyun Jeong Kang; Dae Hwan Kim; Tae-Yong Jeon; Soo-Han Lee; Nari Shin; Sue-Hye Chae; Gwang Ha Kim; Geum Am Song; Dong-Heon Kim; Amitabh Srivastava; Do Youn Park; Gregory Y Lauwers
Journal:  Gastrointest Endosc       Date:  2010-06-15       Impact factor: 9.427

9.  Treatment and outcome of patients with gastric remnant cancer after resection for peptic ulcer disease.

Authors:  James J Mezhir; Mithat Gonen; John B Ammori; Vivian E Strong; Murray F Brennan; Daniel G Coit
Journal:  Ann Surg Oncol       Date:  2010-11-10       Impact factor: 5.344

10.  Evaluation of a new staging system by the Japanese Research Society for Gastric Cancer.

Authors:  T Ochiai; H Hayashi; T Suzuki; K Nakajima; H Shimada; E Hishikawa; A Yasumoto; A Takeda; K Isono
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

View more
  15 in total

1.  Endoscopic submucosal dissection for early neoplastic lesions in the surgically altered stomach: a systematic review and meta-analysis.

Authors:  Mohamed Barakat; Mohamed Seif; Mohamed M Abdelfatah; Andrew Ofosu; David L Carr-Locke; Mohamed O Othman
Journal:  Surg Endosc       Date:  2019-04-08       Impact factor: 4.584

2.  A new pN staging system based on both the number and anatomic location of metastatic lymph nodes in gastric cancer.

Authors:  Jianhui Chen; Chuangqi Chen; Yulong He; KaiMing Wu; Hui Wu; Shirong Cai
Journal:  J Gastrointest Surg       Date:  2014-10-09       Impact factor: 3.452

3.  Outcomes after completion total gastrectomy for gastric remnant cancer: experience from a Canadian tertiary centre.

Authors:  Etienne St-Louis; Stephen Donald Gowing; Pedram Mossallanejad; Mara Laura Leimanis; Carmen Mueller; Lorenzo Edwin Ferri
Journal:  Can J Surg       Date:  2018-08       Impact factor: 2.089

4.  Monitoring of peri-distal gastrectomy carbohydrate antigen 19-9 level in gastric juice and its significance.

Authors:  A-Man Xu; Lei Huang; Wen-Xiu Han; Zhi-Jian Wei
Journal:  Int J Clin Exp Med       Date:  2014-01-15

5.  Detection of perioperative cancer antigen 72-4 in gastric juice pre- and post-distal gastrectomy and its significances.

Authors:  Lei Huang; Aman Xu; Tuanjie Li; Wenxiu Han; Shanshan Wu; Yangyi Wang
Journal:  Med Oncol       Date:  2013-07-03       Impact factor: 3.064

Review 6.  Current status in remnant gastric cancer after distal gastrectomy.

Authors:  Masaichi Ohira; Takahiro Toyokawa; Katsunobu Sakurai; Naoshi Kubo; Hiroaki Tanaka; Kazuya Muguruma; Masakazu Yashiro; Naoyoshi Onoda; Kosei Hirakawa
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 7.  Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Takeo Fukagawa; Yoshio Haga; Koji Oba
Journal:  Gastric Cancer       Date:  2015-12-14       Impact factor: 7.370

8.  An application study of CT perfusion imaging in assessing metastatic involvement of perigastric lymph nodes in patients with T1 gastric cancer.

Authors:  Zongqiong Sun; Shudong Hu; Jie Li; Teng Wang; Zhihui Xie; Linfang Jin
Journal:  Br J Radiol       Date:  2019-12-03       Impact factor: 3.039

9.  Gastric stump cancer: more than just another proximal gastric cancer and demanding a more suitable TNM staging system.

Authors:  André Costa-Pinho; J Pinto-de-Sousa; José Barbosa; J Costa-Maia
Journal:  Biomed Res Int       Date:  2013-09-16       Impact factor: 3.411

10.  Prognostic value of tumor size in patients with remnant gastric cancer: is the seventh UICC stage sufficient for predicting prognosis?

Authors:  Jun Lu; Chang-ming Huang; Chao-hui Zheng; Ping Li; Jian-wei Xie; Jia-bin Wang; Jian-xian Lin; Qi-yue Chen; Long-long Cao; Mi Lin
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.